TXMD TherapeuticsMD Dashboard

TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.

Company profile

Ticker

TXMD

Exchange

NASDAQ

Website

www.therapeuticsmd.com/

CEO

Robert Finizio

Incorporated

Nevada

Location

Florida

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Merck & Co • Allergan • Johnson & Johnson • Abbott Laboratories • Teva- Pharmaceutical Industries • Viatris • Bristol-Myers Squibb • Lilly(Eli) & Co • Warner Chilcott ...

Former names

AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO

SEC CIK

0000025743

Corporate docs

Articles of Incorporation & Bylaws

IRS number

870233535

TXMD stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

9 Apr 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8)

30 Stocks Moving in Friday's Pre-Market Session

9 Apr 21

Gainers

10 Stocks Moving In Thursday's After-Hours Session

8 Apr 21

Gainers FuboTV (NYSE: FUBO) shares are trading higher after the company announced it acquired exclusive streaming rights to the Qatar World Cup 2022 Qualifying matches of South American Football Confederation.

TherapeuticsMD And Theramex Announce The Approval Of Its BIJUVE Capsules Indicated For Hormone Replacement Therapy In The United Kingdom And Under The Trade Name BIJUVA In Belgium

8 Apr 21

10 Health Care Stocks Showing Unusual Options Activity In Today's Session

3 Mar 21

Press releases

Pro users get this 30m faster

Thinking about buying stock in Affimed NV, Geovax Labs, TherapeuticsMD, Fortress Biotech, or Fubotv?

9 Apr 21

NEW YORK, April 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AFMD, GOVX, TXMD, FBIO, and FUBO.

TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium

8 Apr 21

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, and Theramex, a dedicated women's health company, announced that BIJUVE® has received approval from the Medicines and

Thinking about buying stock in Ovid Therapeutics, KemPharm, Super League Gaming, Heat Biologics, or TherapeuticsMD?

3 Mar 21

NEW YORK, March 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OVID, KMPH, SLGG, HTBX, and TXMD.

Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?

2 Mar 21

TherapeuticsMD, Inc. to Host Earnings Call

2 Mar 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

3 Mar 21

18 Apr 21

31 Dec 21

Financial summary

Financial statements Chart TXMD financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	80.49M	80.49M	80.49M	80.49M	80.49M	80.49M
Cash burn (monthly)	(positive/no burn)	6.7M	14.03M	15.29M	10.11M	13.29M
Cash used (since last report)	n/a	24.15M	50.6M	55.16M	36.46M	47.93M
Cash remaining	n/a	56.34M	29.88M	25.32M	44.03M	32.55M
Runway (months of cash)	n/a	8.4	2.1	1.7	4.4	2.4

Beta Read what these cash burn values mean

Recent insider trades

TXMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Mar 21	Finizio Robert G	Common Stock	Gift	Dispose G	No	No	0	350,000	0	18,201,000
4 Mar 21	Milligan John C.K. IV	Common Stock	Payment of exercise	Dispose F	No	No	1.46	29,964	43.75K	1,693,455
4 Mar 21	Milligan John C.K. IV	Common Stock		Aquire X	No	No	0.2444	179,000	43.75K	1,723,419
4 Mar 21	Milligan John C.K. IV	Warrant Common Stock		Dispose X	No	No	0.2444	179,000	43.75K	0
4 Mar 21	Finizio Robert G	Common Stock	Payment of exercise	Dispose F	No	No	1.46	29,964	43.75K	18,551,000
4 Mar 21	Finizio Robert G	Common Stock		Aquire X	No	No	0.2444	179,000	43.75K	18,580,964
4 Mar 21	Finizio Robert G	Warrants Common Stock		Dispose X	No	No	0.2444	179,000	43.75K	0
24 Nov 20	Finizio Robert G	RSU Common Stock	Grant	Aquire A	No	No	0	1	0	1
24 Nov 20	Milligan John C.K. IV	RSU Common Stock	Grant	Aquire A	No	No	0	360,000	0	360,000
24 Nov 20	Donegan Michael C	RSU Common Stock	Grant	Aquire A	No	No	0	230,000	0	230,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

TXMD institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

41.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	158	140	+12.9%
Opened positions	31	15	+106.7%
Closed positions	13	22	-40.9%
Increased positions	45	32	+40.6%
Reduced positions	39	48	-18.8%

13F shares	Current	Prev Q	Change
Total value	470.61M	249.26M	+88.8%
Total shares	161.17M	157.53M	+2.3%
Total puts	853.1K	874.5K	-2.4%
Total calls	573K	838.3K	-31.6%
Total put/call ratio	1.5	1.0	+42.7%

Largest owners	Shares	Value	Change
BLK Blackrock	21.42M	$25.92M	+14.6%
TROW T. Rowe Price	18.87M	$22.83M	-1.0%
FMR	14.12M	$17.08M	-1.4%
Vanguard	13.17M	$15.93M	+3.1%
MS Morgan Stanley	9.28M	$11.23M	+6296.3%
Ra Capital Management	7.81M	$9.45M	NEW
C WorldWide Group Holding A/S	6.19M	$7.49M	0.0%
GMT Capital	5.99M	$7.24M	0.0%
AMP Ameriprise Financial	4.6M	$5.57M	+11.6%
Rubric Capital Management	4.52M	$5.47M	-67.6%

Largest transactions	Shares	Bought/sold	Change
JPM JPMorgan Chase & Co.	674.04K	-12.49M	-94.9%
Rubric Capital Management	4.52M	-9.41M	-67.6%
MS Morgan Stanley	9.28M	+9.13M	+6296.3%
Ra Capital Management	7.81M	+7.81M	NEW
Laurion Capital Management	3.31M	+3.31M	NEW
BLK Blackrock	21.42M	+2.73M	+14.6%
Islet Management	0	-1.5M	EXIT
AXAHF Axa	4.5M	+1.11M	+32.7%
GS Goldman Sachs	1.15M	-940.96K	-45.0%
D. E. Shaw & Co.	845.61K	+761.34K	+903.4%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Pfizer • Amag Pharmaceuticals • Agile Therapeutics • Allergan • Mylan II B.V. • Amneal Pharmaceuticals

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Actonel, AIG, alike, appendix, ASP, attached, Biden, Bisaro, blockbuster, Boniva, Borkowski, buyer, Cantor, chaired, choice, CMPL, coagulation, combat, complaint, conserve, counterclaim, covenant, CPRA, cutting, deferral, depression, discretionary, displaced, disregard, distancing, disturbance, divestiture, divesture, EBITDA, Edward, entertainment, equitable, ESPP, EU, Evista, explicitly, Facebook, FDRR, feasibility, fifteen, Fitzgerald, Forteo, Gail, home, immunity, intentionally, Interbank, intervene, Ireland, Jersey, Karen, landscape, legislature, Ling, lipid, London, MFN, micronized, Musing, Naughton, occupy, OfferingSM, onboarded, onboarding, override, overturned, pandemic, Paul, pause, paused, Pennsylvania, Peter, pharmacological, Poor, preapproval, prevail, privilege, purport, quarantine, ramping, reassessed, reassessment, recession, reconciled, refill, refocused, registry, relaunched, rescinded, rescission, Resolution, restarted, resume, resumed, reverted, round, Sandoz, sentence, Sentinel, shifted, shortage, signaling, slower, sooner, sophisticated, spread, styled, subsided, Sun, talent, temporarily, text, uncovered, undo, undrawn, unemployment, upholding, vaccine, vagina, Vice, vouching, withdrew, workforce, Workplace, worse

Removed: Allergan, amag, Brian, buy, called, capacity, capitalization, Cartwright, century, Daniel, deteriorate, easier, elderly, enact, exempting, expressed, financed, geographic, idling, improvement, Intrarosa, Jr, LaPenta, Mine, MMA, PA, provisional, Quatrefolic, reached, referring, repealed, Stark, submitting, Supplementary, Treasurer, unqualified, vendor

From filing 10-K 2020 FY